Tenon Medical, Inc. (TNON)

Market Cap	5.77M
Revenue (ttm)	3.32M
Net Income (ttm)	-13.72M
Shares Out	3.14M
EPS (ttm)	-27.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	258,283
Open	1.950
Previous Close	1.920
Day's Range	1.840 - 1.970
52-Week Range	1.810 - 17.190
Beta	1.92
Analysts	Strong Buy
Price Target	16.00 (+769.57%)
Earnings Date	Nov 13, 2024

About TNON

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Ga...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 27, 2022
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: TNON
• Website: https://www.tenonmed.com

Financial Performance

In 2023, Tenon Medical's revenue was $2.93 million, an increase of 323.73% compared to the previous year's $691,000. Losses were -$15.58 million, -17.63% less than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for TNON stock is "Strong Buy." The 12-month stock price forecast is $16.0, which is an increase of 769.57% from the latest price.

Price Target

$16.0

(769.57% upside)

Analyst Consensus: Strong Buy